T. Ashwood

1.1k total citations
20 papers, 818 citations indexed

About

T. Ashwood is a scholar working on Epidemiology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, T. Ashwood has authored 20 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Psychiatry and Mental health and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in T. Ashwood's work include Acute Ischemic Stroke Management (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Stroke Rehabilitation and Recovery (4 papers). T. Ashwood is often cited by papers focused on Acute Ischemic Stroke Management (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Stroke Rehabilitation and Recovery (4 papers). T. Ashwood collaborates with scholars based in United Kingdom, United States and Sweden. T. Ashwood's co-authors include H.V. Wheal, L. Claesson, Barrie Lancaster, Thierry Rosolacci, Tomas Odergren, B. Lancaster, N.G. Wahlgren, P.M.M. van Erven, C L Franke and Patrick D. Lyden and has published in prestigious journals such as Neurology, The Journal of Physiology and Stroke.

In The Last Decade

T. Ashwood

20 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Ashwood United Kingdom 14 339 273 228 184 184 20 818
Thomas J. Chippendale United States 7 114 0.3× 180 0.7× 85 0.4× 102 0.6× 108 0.6× 8 599
S. Engelborghs Belgium 16 144 0.4× 108 0.4× 196 0.9× 251 1.4× 127 0.7× 26 1.0k
Deniz Erten‐Lyons United States 16 188 0.6× 103 0.4× 222 1.0× 119 0.6× 113 0.6× 33 1.1k
László Csiba Hungary 11 215 0.6× 58 0.2× 78 0.3× 135 0.7× 74 0.4× 21 705
Joelle M. Scanlon United States 14 115 0.3× 199 0.7× 59 0.3× 186 1.0× 183 1.0× 17 729
Ayesha Sherzai United States 16 195 0.6× 69 0.3× 102 0.4× 174 0.9× 258 1.4× 33 1.1k
B. Reinhart Austria 12 82 0.2× 85 0.3× 132 0.6× 72 0.4× 188 1.0× 21 970
Anne Rita Øksengård Norway 13 74 0.2× 131 0.5× 105 0.5× 67 0.4× 57 0.3× 20 492
Christian Lange‐Asschenfeldt Germany 14 210 0.6× 35 0.1× 110 0.5× 147 0.8× 107 0.6× 57 773
A. Santangelo Italy 17 262 0.8× 375 1.4× 179 0.8× 272 1.5× 180 1.0× 44 1.3k

Countries citing papers authored by T. Ashwood

Since Specialization
Citations

This map shows the geographic impact of T. Ashwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Ashwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Ashwood more than expected).

Fields of papers citing papers by T. Ashwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Ashwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Ashwood. The network helps show where T. Ashwood may publish in the future.

Co-authorship network of co-authors of T. Ashwood

This figure shows the co-authorship network connecting the top 25 collaborators of T. Ashwood. A scholar is included among the top collaborators of T. Ashwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Ashwood. T. Ashwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Greenberg, Barry, María C. Carrillo, J. Michael Ryan, et al.. (2012). Improving Alzheimer's disease phase II clinical trials. Alzheimer s & Dementia. 9(1). 39–49. 24 indexed citations
3.
Lyden, Patrick D., Ashfaq Shuaib, Kim Tien Ng, et al.. (2002). Clomethiazole Acute Stroke Study in Ischemic Stroke (CLASS-I). Stroke. 33(1). 122–129. 129 indexed citations
4.
Lyden, Patrick, Michael Jacoby, Jack Schim, et al.. (2001). The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator–treated stroke (CLASS-T). Neurology. 57(7). 1199–1205. 56 indexed citations
5.
Wahlgren, N.G., et al.. (2000). The clomethiazole acute stroke study (CLASS): Safety results in 1,356 patients with acute hemispheric stroke. Journal of Stroke and Cerebrovascular Diseases. 9(4). 158–165. 11 indexed citations
6.
Wahlgren, Nils, Exuperio Díez‐Tejedor, Jeanne Teitelbaum, et al.. (2000). Results in 95 Hemorrhagic Stroke Patients Included in CLASS, a Controlled Trial of Clomethiazole Versus Placebo in Acute Stroke Patients. Stroke. 31(1). 82–85. 35 indexed citations
7.
Lyden, Patrick D., Ashfaq Shuaib, Ken Ng, et al.. (2000). The Clomethiazole Acute Stroke Study in hemorrhagic stroke (Class-H): Final results. Journal of Stroke and Cerebrovascular Diseases. 9(6). 268–275. 10 indexed citations
8.
Wahlgren, Nils, Anil Kumar Sharma, Björn Cederin, et al.. (1999). The clomethiazole acute stroke study (CLASS): Efficacy results in 545 patients classified as total anterior circulation syndrome (TACS). Journal of Stroke and Cerebrovascular Diseases. 8(4). 231–239. 40 indexed citations
9.
Wahlgren, N.G., Thierry Rosolacci, C L Franke, et al.. (1999). Clomethiazole Acute Stroke Study (CLASS). Stroke. 30(1). 21–28. 125 indexed citations
10.
Lyden, Patrick D., T. Ashwood, L. Claesson, et al.. (1998). The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada. Journal of Stroke and Cerebrovascular Diseases. 7(6). 435–441. 22 indexed citations
11.
Ashwood, T., Cosmo Hallström, Daniel Griffiths-King, Mark Livingston, & Robin G. McCreadie. (1992). An open study of remoxipride in the long-term treatment of schizophrenia-. Journal of Psychopharmacology. 6(4). 519–525. 2 indexed citations
12.
Ashwood, T., et al.. (1991). A Single-dose Study of the Pharmacodynamic Effects of Chlormethiazole, Temazepam and Placebo in Elderly Parkinsonian Patients. Age and Ageing. 20(6). 424–429. 6 indexed citations
13.
14.
15.
Ashwood, T. & H.V. Wheal. (1987). The expression of N‐methyl‐d‐aspartate‐receptor‐mediated component during epileptiform synaptic activity in the hippocampus. British Journal of Pharmacology. 91(4). 815–822. 33 indexed citations
16.
Ashwood, T., G.L. Collingridge, Caroline E. Herron, & H.V. Wheal. (1987). Voltage‐clamp analysis of somatic gamma‐aminobutyric acid responses in adult rat hippocampal CA1 neurones in vitro.. The Journal of Physiology. 384(1). 27–37. 24 indexed citations
17.
Ashwood, T. & H.V. Wheal. (1986). Extracellular studies on the role of N-methyl-d-aspartate receptors in epileptiform activity recorded from the kainic acid-lesioned hippocampus. Neuroscience Letters. 67(2). 147–152. 26 indexed citations
18.
Ashwood, T. & H.V. Wheal. (1986). Loss of inhibition in the CA1 region of the kainic acid lesioned hippocampus is not associated with changes in postsynaptic responses to GABA. Brain Research. 367(1-2). 390–394. 35 indexed citations
19.
Ashwood, T., B. Lancaster, & H.V. Wheal. (1986). Intracellular electrophysiology of CA1 pyramidal neurones in slices of the kainic acid lesioned hippocampus of the rat. Experimental Brain Research. 62(1). 189–98. 65 indexed citations
20.
Ashwood, T., Barrie Lancaster, & H.V. Wheal. (1984). In vivo and in vitro studies on putative interneurones in the rat hippocampus: Possible mediators of feed-forward inhibition. Brain Research. 293(2). 279–291. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas J. Chippendale Breakdown of academic impact, for papers by S. Engelborghs Breakdown of academic impact, for papers by Deniz Erten‐Lyons Breakdown of academic impact, for papers by László Csiba Breakdown of academic impact, for papers by Joelle M. Scanlon Breakdown of academic impact, for papers by Ayesha Sherzai Breakdown of academic impact, for papers by B. Reinhart Breakdown of academic impact, for papers by Anne Rita Øksengård Breakdown of academic impact, for papers by Christian Lange‐Asschenfeldt Breakdown of academic impact, for papers by A. Santangelo
Rankless by CCL
2026